Global Digital Health & AI Tools in Neuroscience Market - 2025 -2033
Digital Health & AI Tools in Neuroscience Market Size& Industry Outlook
The global digital health & AI tools in neuroscience market size reached US$ 31.25billion with rise of US$34.10billion in 2024 is expected to reach US$ 79.30billion by 2033, growing at a CAGR of 9.9%during the forecast period 2025-2033.
A major driving factor propelling this market is the surge in partnerships between big technology firms, healthcare providers, and pharma companies to develop integrated AI-driven neuroscience solutions. Instead of isolated apps or devices, stakeholders are co-creating full digital ecosystems that combine imaging, biomarker analysis, remote monitoring, and personalized interventions. For instance, in 2024, Biofourmis has teamed up with major hospital networks and life-science companies to deploy its AI-enabled remote patient monitoring platform for neurological and cardiac patients, showing how cross-sector partnerships can bring advanced digital health tools into real-world care pathways more quickly and at scale.
Key Highlights
Drivers:
Rising prevalence of neurological and psychiatric disorders worldwide is significantly driving the Digital Health & AI Tools in Neuroscience market growth
The rising prevalence of neurological and psychiatric disorders is a major driver for the growth of digital health and AI tools in neuroscience. These technologies enable early diagnosis, continuous monitoring, personalized treatment, and remote management of complex brain disorders, which traditional methods often struggle to provide at scale. AI algorithms can analyze brain imaging, EEG signals, and behavioral data, while digital therapeutics offer targeted interventions for conditions like ADHD, depression, and cognitive decline. By improving clinical outcomes and accessibility, these tools address a critical unmet need in global healthcare systems.
Globally, more than 3.4 billion people (~43% of the population) were living with at least one neurological condition in 2021, resulting in 443 million disability adjusted life years (DALYs) lost. Mental health conditions affect over 1 billion people worldwide, with anxiety and depression among the most common disorders. In low and middle income countries, treatment gaps are substantial, exceeding 50–75%, highlighting the urgent need for scalable AI- and digital-based interventions.
Restraints:
High cost of advanced neuro-AI tools are hampering the growth of the Digital Health & AI Tools in Neuroscience market
One of the biggest barriers to wider adoption of digital health and AI tools in neuroscience is their high upfront and operating costs, which limit access for smaller clinics and emerging markets. Advanced braincomputer interface implants and AI-driven neurodiagnostic platforms can cost anywhere from USD 50,000–100,000 per unit for hospital-grade systems, while cloud-based analytics and subscription fees for AI platforms can add USD 500–1,500 per patient per month. These high costs slow down reimbursement approvals and make it harder for providers to scale such solutions beyond pilot programs.
Segmentation Analysis
The global digital health & AI tools in neuroscience market is segmented based on component, technology, application, end user, and region.
Component:
The software segment from component segment to dominate the digital health & AI tools in neuroscience market with a 45.1% share in 2024
The software segment drives the growth of the neuroscience digital health market by enhancing accessibility, efficiency, and precision in the management of neurological disorders. AI-powered applications and digital platforms allow clinicians to remotely monitor patients, track cognitive performance, and analyze patterns in real time, which is particularly valuable for chronic conditions like Alzheimer’s, Parkinson’s, and epilepsy.
Additionally, software solutions facilitate integration of multi-modal data including imaging, biomarkers, and patient reported outcomes into actionable insights for treatment planning. For example, platforms developed by Neuroelectric and Pear Therapeutics help deliver personalized interventions and adaptive therapies, improving patient engagement while reducing the strain on healthcare systems. By enabling continuous, data-driven care, the software segment accelerates the adoption of digital health tools across hospitals, clinics, and home-based care settings.
Application:
The Alzheimer's / dementia segment is estimated to have a 41.2% of the digital health & AI tools in neuroscience market share in 2024
The Alzheimer’s and dementia segment is a major driver of the digital health and AI tools market due to the growing global burden of cognitive disorders and the urgent need for early detection and personalized care. With millions of patients affected worldwide and limited treatment options, healthcare systems are increasingly adopting AI-powered software, digital therapeutics, and remote monitoring platforms to improve diagnosis, track disease progression, and manage symptoms effectively.
Applications such as cognitive assessment tools, memory training programs, and AI-based imaging analytics allow clinicians to identify subtle cognitive changes early, personalize interventions, and reduce hospital visits. Companies like Alto Neuroscience and BrainSightAI are leveraging these applications to provide actionable insights for clinicians and caregivers, making Alzheimer’s and dementia management a key growth area in the neuroscience digital health market.
Geographical Analysis
North America dominates the global Digital Health & AI Tools in Neuroscience market with a 43.5% in 2024
The North American market is driven by high healthcare expenditure, advanced healthcare infrastructure, and early adoption of innovative digital technologies. The region has strong R&D capabilities and supportive government initiatives promoting AI in healthcare, leading to widespread deployment of neurodiagnostic software, digital therapeutics, and remote monitoring solutions. Rising awareness of neurological disorders among clinicians and patients’ further fuels market growth.
In the USA specifically, the market growth is propelled by robust investment in AI research, high prevalence of neurological and psychiatric disorders, and favorable reimbursement policies. Healthcare providers are increasingly adopting AI-based platforms for early diagnosis, personalized treatment, and continuous monitoring, while collaborations between tech companies and academic institutions accelerate innovation and commercialization.
For instance, in July 2025, Linus Health, an AI-focused brain health company specializing in early detection of cognitive impairment and personalized interventions, has announced the expanded launch of Anywhere powered by Linus Health. This clinically validated cognitive assessment platform leverages artificial intelligence to provide accessible and scalable brain health solutions for both in-clinic and remote use, reaching a wide range of users, including payers, pharmaceutical companies, wellness providers, and consumers.
Europe is the second region after North America which is expected to dominate the global Digital Health & AI Tools in Neuroscience market with a 34.5% in 2024
Europe’s growth is supported by an aging population, increasing incidence of cognitive and neurological disorders, and well-established healthcare systems. Government policies encouraging digital health adoption, along with cross-border research collaborations, are enabling hospitals and clinics to integrate AI-powered diagnostics and digital therapeutics into standard care for brain disorders.
Germany, country in this market, is driven by advanced healthcare infrastructure, supportive digital health regulations, and high adoption of AI-based clinical solutions. Hospitals and specialized clinics are leveraging AI software for Alzheimer’s, dementia, stroke, and neurorehabilitation applications, supported by strong public and private funding for neuroscience research and innovation.
The Asia Pacific region is the fastest-growing region in the global Digital Health & AI Tools in Neuroscience market, with a CAGR of 8.1% in 2024
The Asia-Pacific market is experiencing growth due to rapidly aging populations, increasing prevalence of neurological disorders, and government initiatives promoting digital and AI-based healthcare solutions. Countries in the region are adopting remote monitoring, digital therapeutics, and AI-powered diagnostic tools to manage the growing burden of cognitive and psychiatric disorders efficiently, especially in urban centers.
Japan’s market expansion is driven by the world’s highest proportion of elderly citizens, rising dementia cases, and strong government support for smart healthcare technologies. AI-driven neurodiagnostics, cognitive assessment software, and remote patient monitoring are increasingly deployed in hospitals and long-term care facilities to improve early detection, disease management, and patient outcomes, positioning Japan as a key regional leader in neuroscience digital health adoption.
Digital Health & AI Tools in Neuroscience Market Competitive Landscape
Top companies in the Digital Health & AI Tools in Neuroscience market includeAkili Interactive, Pear Therapeutics, Biofourmis, Empatica, Neuroelectric, Neural ink, Blackrock Neurotech, Synchron, MindMaze, Precision Neuroscience and among others.
Akili Interactive: Akili Interactive primarily operates in the software segment of the neuroscience digital health market, leveraging AI-driven digital therapeutics to treat cognitive and neurological disorders. Its flagship product, EndeavorRx, is a prescription-based, gamified therapeutic software designed to improve attention in children with ADHD, demonstrating how software alone can serve as a clinically validated intervention. While Akili’s focus is on software, it complements hardware indirectly by being compatible with tablets, PCs, and other devices, allowing scalable deployment across home and clinical settings.
The global Digital Health & AI Tools in Neuroscience market report delivers a detailed analysis with 62 key tables, more than 57visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
The global digital health & AI tools in neuroscience market size reached US$ 31.25billion with rise of US$34.10billion in 2024 is expected to reach US$ 79.30billion by 2033, growing at a CAGR of 9.9%during the forecast period 2025-2033.
A major driving factor propelling this market is the surge in partnerships between big technology firms, healthcare providers, and pharma companies to develop integrated AI-driven neuroscience solutions. Instead of isolated apps or devices, stakeholders are co-creating full digital ecosystems that combine imaging, biomarker analysis, remote monitoring, and personalized interventions. For instance, in 2024, Biofourmis has teamed up with major hospital networks and life-science companies to deploy its AI-enabled remote patient monitoring platform for neurological and cardiac patients, showing how cross-sector partnerships can bring advanced digital health tools into real-world care pathways more quickly and at scale.
Key Highlights
- North America dominates the digital health & AI tools in neuroscience market with the largest revenue share of 43.5% in 2024.
- The Asia Pacific is the fastest-growing region and is expected to grow at the fastest CAGR of8.1% over the forecast period.
- Based on component, software segmented the market with the largest revenue share of 45.1% in 2024.
- The major market players in the Akili Interactive, Pear Therapeutics, Biofourmis, Emphatical, Neuroelectric, Neural ink, Blackrock Neurotech, Synchrony, MindMaze, Precision Neuroscience and among others.
Drivers:
Rising prevalence of neurological and psychiatric disorders worldwide is significantly driving the Digital Health & AI Tools in Neuroscience market growth
The rising prevalence of neurological and psychiatric disorders is a major driver for the growth of digital health and AI tools in neuroscience. These technologies enable early diagnosis, continuous monitoring, personalized treatment, and remote management of complex brain disorders, which traditional methods often struggle to provide at scale. AI algorithms can analyze brain imaging, EEG signals, and behavioral data, while digital therapeutics offer targeted interventions for conditions like ADHD, depression, and cognitive decline. By improving clinical outcomes and accessibility, these tools address a critical unmet need in global healthcare systems.
Globally, more than 3.4 billion people (~43% of the population) were living with at least one neurological condition in 2021, resulting in 443 million disability adjusted life years (DALYs) lost. Mental health conditions affect over 1 billion people worldwide, with anxiety and depression among the most common disorders. In low and middle income countries, treatment gaps are substantial, exceeding 50–75%, highlighting the urgent need for scalable AI- and digital-based interventions.
Restraints:
High cost of advanced neuro-AI tools are hampering the growth of the Digital Health & AI Tools in Neuroscience market
One of the biggest barriers to wider adoption of digital health and AI tools in neuroscience is their high upfront and operating costs, which limit access for smaller clinics and emerging markets. Advanced braincomputer interface implants and AI-driven neurodiagnostic platforms can cost anywhere from USD 50,000–100,000 per unit for hospital-grade systems, while cloud-based analytics and subscription fees for AI platforms can add USD 500–1,500 per patient per month. These high costs slow down reimbursement approvals and make it harder for providers to scale such solutions beyond pilot programs.
Segmentation Analysis
The global digital health & AI tools in neuroscience market is segmented based on component, technology, application, end user, and region.
Component:
The software segment from component segment to dominate the digital health & AI tools in neuroscience market with a 45.1% share in 2024
The software segment drives the growth of the neuroscience digital health market by enhancing accessibility, efficiency, and precision in the management of neurological disorders. AI-powered applications and digital platforms allow clinicians to remotely monitor patients, track cognitive performance, and analyze patterns in real time, which is particularly valuable for chronic conditions like Alzheimer’s, Parkinson’s, and epilepsy.
Additionally, software solutions facilitate integration of multi-modal data including imaging, biomarkers, and patient reported outcomes into actionable insights for treatment planning. For example, platforms developed by Neuroelectric and Pear Therapeutics help deliver personalized interventions and adaptive therapies, improving patient engagement while reducing the strain on healthcare systems. By enabling continuous, data-driven care, the software segment accelerates the adoption of digital health tools across hospitals, clinics, and home-based care settings.
Application:
The Alzheimer's / dementia segment is estimated to have a 41.2% of the digital health & AI tools in neuroscience market share in 2024
The Alzheimer’s and dementia segment is a major driver of the digital health and AI tools market due to the growing global burden of cognitive disorders and the urgent need for early detection and personalized care. With millions of patients affected worldwide and limited treatment options, healthcare systems are increasingly adopting AI-powered software, digital therapeutics, and remote monitoring platforms to improve diagnosis, track disease progression, and manage symptoms effectively.
Applications such as cognitive assessment tools, memory training programs, and AI-based imaging analytics allow clinicians to identify subtle cognitive changes early, personalize interventions, and reduce hospital visits. Companies like Alto Neuroscience and BrainSightAI are leveraging these applications to provide actionable insights for clinicians and caregivers, making Alzheimer’s and dementia management a key growth area in the neuroscience digital health market.
Geographical Analysis
North America dominates the global Digital Health & AI Tools in Neuroscience market with a 43.5% in 2024
The North American market is driven by high healthcare expenditure, advanced healthcare infrastructure, and early adoption of innovative digital technologies. The region has strong R&D capabilities and supportive government initiatives promoting AI in healthcare, leading to widespread deployment of neurodiagnostic software, digital therapeutics, and remote monitoring solutions. Rising awareness of neurological disorders among clinicians and patients’ further fuels market growth.
In the USA specifically, the market growth is propelled by robust investment in AI research, high prevalence of neurological and psychiatric disorders, and favorable reimbursement policies. Healthcare providers are increasingly adopting AI-based platforms for early diagnosis, personalized treatment, and continuous monitoring, while collaborations between tech companies and academic institutions accelerate innovation and commercialization.
For instance, in July 2025, Linus Health, an AI-focused brain health company specializing in early detection of cognitive impairment and personalized interventions, has announced the expanded launch of Anywhere powered by Linus Health. This clinically validated cognitive assessment platform leverages artificial intelligence to provide accessible and scalable brain health solutions for both in-clinic and remote use, reaching a wide range of users, including payers, pharmaceutical companies, wellness providers, and consumers.
Europe is the second region after North America which is expected to dominate the global Digital Health & AI Tools in Neuroscience market with a 34.5% in 2024
Europe’s growth is supported by an aging population, increasing incidence of cognitive and neurological disorders, and well-established healthcare systems. Government policies encouraging digital health adoption, along with cross-border research collaborations, are enabling hospitals and clinics to integrate AI-powered diagnostics and digital therapeutics into standard care for brain disorders.
Germany, country in this market, is driven by advanced healthcare infrastructure, supportive digital health regulations, and high adoption of AI-based clinical solutions. Hospitals and specialized clinics are leveraging AI software for Alzheimer’s, dementia, stroke, and neurorehabilitation applications, supported by strong public and private funding for neuroscience research and innovation.
The Asia Pacific region is the fastest-growing region in the global Digital Health & AI Tools in Neuroscience market, with a CAGR of 8.1% in 2024
The Asia-Pacific market is experiencing growth due to rapidly aging populations, increasing prevalence of neurological disorders, and government initiatives promoting digital and AI-based healthcare solutions. Countries in the region are adopting remote monitoring, digital therapeutics, and AI-powered diagnostic tools to manage the growing burden of cognitive and psychiatric disorders efficiently, especially in urban centers.
Japan’s market expansion is driven by the world’s highest proportion of elderly citizens, rising dementia cases, and strong government support for smart healthcare technologies. AI-driven neurodiagnostics, cognitive assessment software, and remote patient monitoring are increasingly deployed in hospitals and long-term care facilities to improve early detection, disease management, and patient outcomes, positioning Japan as a key regional leader in neuroscience digital health adoption.
Digital Health & AI Tools in Neuroscience Market Competitive Landscape
Top companies in the Digital Health & AI Tools in Neuroscience market includeAkili Interactive, Pear Therapeutics, Biofourmis, Empatica, Neuroelectric, Neural ink, Blackrock Neurotech, Synchron, MindMaze, Precision Neuroscience and among others.
Akili Interactive: Akili Interactive primarily operates in the software segment of the neuroscience digital health market, leveraging AI-driven digital therapeutics to treat cognitive and neurological disorders. Its flagship product, EndeavorRx, is a prescription-based, gamified therapeutic software designed to improve attention in children with ADHD, demonstrating how software alone can serve as a clinically validated intervention. While Akili’s focus is on software, it complements hardware indirectly by being compatible with tablets, PCs, and other devices, allowing scalable deployment across home and clinical settings.
The global Digital Health & AI Tools in Neuroscience market report delivers a detailed analysis with 62 key tables, more than 57visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet byComponent
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet byEnd User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Neurological and Psychiatric Disorders Worldwide
3.1.1.2. Increasing Adoption of AI And Digital Health Platforms
3.1.2. Restraints
3.1.2.1. High Cost of Advanced Neuro-AI Tools
3.1.2.2. Data Privacy, Security and Regulatory Compliance Challenges
3.1.3. Opportunity
3.1.3.1. Expansion of Personalized/Precision Digital Therapeutics for Brain Disorders
3.1.3.2. Growing Collaborations Between Tech Firms and Pharma/Health Systems
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY COMPONENT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
5.1.2. Market Attractiveness Index, By Component
5.2. Software*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Hardware
5.4. Services
6. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY TECHNOLOGY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Machine Learning*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Signal Processing
6.4. Virtual Reality
6.5. Cloud / Compute & GPU Providers
7. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Alzheimer’s / Dementia*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Stroke & Neurorehabilitation
7.4. Epilepsy / Seizure Monitoring
7.5. Mental Health / Psychiatric Disorders
8. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Specialty Centers
9. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Akili Interactive*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Pear Therapeutics
11.3. Biofourmis
11.4. Empatica
11.5. Neuroelectrics
11.6. Neuralink
11.7. Blackrock Neurotech
11.8. Synchron
11.9. MindMaze
11.10. Precision Neuroscience ( LIST NOT EXHAUSTIVE )
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet byComponent
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet byEnd User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Neurological and Psychiatric Disorders Worldwide
3.1.1.2. Increasing Adoption of AI And Digital Health Platforms
3.1.2. Restraints
3.1.2.1. High Cost of Advanced Neuro-AI Tools
3.1.2.2. Data Privacy, Security and Regulatory Compliance Challenges
3.1.3. Opportunity
3.1.3.1. Expansion of Personalized/Precision Digital Therapeutics for Brain Disorders
3.1.3.2. Growing Collaborations Between Tech Firms and Pharma/Health Systems
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY COMPONENT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
5.1.2. Market Attractiveness Index, By Component
5.2. Software*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Hardware
5.4. Services
6. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY TECHNOLOGY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Machine Learning*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Signal Processing
6.4. Virtual Reality
6.5. Cloud / Compute & GPU Providers
7. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Alzheimer’s / Dementia*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Stroke & Neurorehabilitation
7.4. Epilepsy / Seizure Monitoring
7.5. Mental Health / Psychiatric Disorders
8. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Specialty Centers
9. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Akili Interactive*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Pear Therapeutics
11.3. Biofourmis
11.4. Empatica
11.5. Neuroelectrics
11.6. Neuralink
11.7. Blackrock Neurotech
11.8. Synchron
11.9. MindMaze
11.10. Precision Neuroscience ( LIST NOT EXHAUSTIVE )
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 8 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 10 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 17 North America Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 18 North America Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 Europe Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 23 Europe Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Europe Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 Europe Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 32 South America Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 33 South America Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 South America Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Akili Interactive: Overview
Table 42 Akili Interactive: Product Portfolio
Table 43 Akili Interactive: Key Developments
Table 44 Pear Therapeutics: Overview
Table 45 Pear Therapeutics: Product Portfolio
Table 46 Pear Therapeutics: Key Developments
Table 47 Biofourmis: Overview
Table 48 Biofourmis: Product Portfolio
Table 49 Biofourmis: Key Developments
Table 50 Empatica: Overview
Table 51 Empatica: Product Portfolio
Table 52 Empatica: Key Developments
Table 53 Neuroelectrics: Overview
Table 54 Neuroelectrics: Product Portfolio
Table 55 Neuroelectrics: Key Developments
Table 56 Neuralink: Overview
Table 57 Neuralink: Product Portfolio
Table 58 Neuralink: Key Developments
Table 59 Blackrock Neurotech: Overview
Table 60 Blackrock Neurotech: Product Portfolio
Table 61 Blackrock Neurotech: Key Developments
Table 62 Synchron: Overview
Table 63 Synchron: Product Portfolio
Table 64 Synchron: Key Developments
Table 65 MindMaze: Overview
Table 66 MindMaze: Product Portfolio
Table 67 MindMaze: Key Developments
Table 68 Precision Neuroscience: Overview
Table 69 Precision Neuroscience: Product Portfolio
Table 70 Precision Neuroscience: Key Developments
Table 1 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 8 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 10 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Digital Health & AI Tools in Neuroscience Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 17 North America Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 18 North America Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 Europe Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 23 Europe Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Europe Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 Europe Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 32 South America Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 33 South America Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 South America Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Component, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Technology, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Akili Interactive: Overview
Table 42 Akili Interactive: Product Portfolio
Table 43 Akili Interactive: Key Developments
Table 44 Pear Therapeutics: Overview
Table 45 Pear Therapeutics: Product Portfolio
Table 46 Pear Therapeutics: Key Developments
Table 47 Biofourmis: Overview
Table 48 Biofourmis: Product Portfolio
Table 49 Biofourmis: Key Developments
Table 50 Empatica: Overview
Table 51 Empatica: Product Portfolio
Table 52 Empatica: Key Developments
Table 53 Neuroelectrics: Overview
Table 54 Neuroelectrics: Product Portfolio
Table 55 Neuroelectrics: Key Developments
Table 56 Neuralink: Overview
Table 57 Neuralink: Product Portfolio
Table 58 Neuralink: Key Developments
Table 59 Blackrock Neurotech: Overview
Table 60 Blackrock Neurotech: Product Portfolio
Table 61 Blackrock Neurotech: Key Developments
Table 62 Synchron: Overview
Table 63 Synchron: Product Portfolio
Table 64 Synchron: Key Developments
Table 65 MindMaze: Overview
Table 66 MindMaze: Product Portfolio
Table 67 MindMaze: Key Developments
Table 68 Precision Neuroscience: Overview
Table 69 Precision Neuroscience: Product Portfolio
Table 70 Precision Neuroscience: Key Developments
LIST OF FIGURES
Figure 1 Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 3 Global Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Digital Health & AI Tools in Neuroscience Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 8 Software Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 9 Hardware Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 10 Services Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 12 Machine Learning Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 13 Signal Processing Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 14 Virtual Reality Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 15 Cloud / Compute & GPU Providers Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 17 Alzheimer’s / Dementia Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 18 Stroke & Neurorehabilitation Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 19 Epilepsy / Seizure Monitoring Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 20 Mental Health / Psychiatric Disorders Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 21 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 22 Hospitals End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 23 Clinics End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 24 Specialty Centers End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 25 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 26 North America Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 27 North America Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 28 North America Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 29 North America Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 30 North America Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 31 North America Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 33 Europe Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 34 Europe Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 35 Europe Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 37 Europe Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 38 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 39 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 40 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 41 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 42 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 43 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 44 South America Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 45 South America Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 46 South America Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 47 South America Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 48 South America Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 49 South America Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 50 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 51 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 52 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 53 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 54 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 55 Akili Interactive: Financials
Figure 56 Pear Therapeutics: Financials
Figure 57 Biofourmis: Financials
Figure 58 Empatica: Financials
Figure 59 Neuroelectrics: Financials
Figure 60 Neuralink: Financials
Figure 61 Blackrock Neurotech: Financials
Figure 62 Synchron: Financials
Figure 63 MindMaze: Financials
Figure 64 Precision Neuroscience: Financials
Figure 1 Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 3 Global Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Digital Health & AI Tools in Neuroscience Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 8 Software Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 9 Hardware Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 10 Services Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 12 Machine Learning Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 13 Signal Processing Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 14 Virtual Reality Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 15 Cloud / Compute & GPU Providers Technology in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 17 Alzheimer’s / Dementia Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 18 Stroke & Neurorehabilitation Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 19 Epilepsy / Seizure Monitoring Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 20 Mental Health / Psychiatric Disorders Application in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 21 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 22 Hospitals End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 23 Clinics End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 24 Specialty Centers End User in Global Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 25 Global Digital Health & AI Tools in Neuroscience Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 26 North America Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 27 North America Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 28 North America Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 29 North America Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 30 North America Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 31 North America Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 33 Europe Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 34 Europe Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 35 Europe Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 37 Europe Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 38 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 39 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 40 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 41 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 42 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 43 Asia-Pacific Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 44 South America Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 45 South America Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 46 South America Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 47 South America Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 48 South America Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 49 South America Digital Health & AI Tools in Neuroscience Market Share, By Country, 2024 & 2033 (%)
Figure 50 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Value, 2022-2033 (US$ Billion)
Figure 51 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Component, 2024 & 2033 (%)
Figure 52 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Technology, 2024 & 2033 (%)
Figure 53 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By Application, 2024 & 2033 (%)
Figure 54 Middle East and Africa Digital Health & AI Tools in Neuroscience Market Share, By End User, 2024 & 2033 (%)
Figure 55 Akili Interactive: Financials
Figure 56 Pear Therapeutics: Financials
Figure 57 Biofourmis: Financials
Figure 58 Empatica: Financials
Figure 59 Neuroelectrics: Financials
Figure 60 Neuralink: Financials
Figure 61 Blackrock Neurotech: Financials
Figure 62 Synchron: Financials
Figure 63 MindMaze: Financials
Figure 64 Precision Neuroscience: Financials
